Young patients diagnosed with systemic lupus erythematosus (SLE) show a high number of visits to healthcare facilities in the year…
Articles by Patricia Inacio, PhD
Corbus Pharmaceuticals has obtained a U.S. patent for the way that its therapy anabasum works to combat lupus, systemic sclerosis,…
Patients with systemic lupus erythematosus (SLE) show significantly higher rates for dementia compared to healthy people, according to a large…
Women with systemic lupus erythematosus (SLE) in the U.S. live on average 22 years less — and men an average…
GlaxoSmithKline’s Benlysta reduced lupus patients’ need for higher doses of corticosteroids, a therapy that is beneficial but causes long-term organ damage, an…
Obese women with systemic lupus erythematosus (SLE) have a poorer quality of life and suffer more symptoms than women of normal…
Janssen announced that its investigational antibody Stelara (ustekinumab) showed positive results in a Phase 2 trial as a therapy for patients…
Nimbus Therapeutics, which uses computer analysis to identify and develop therapies for autoimmune diseases like lupus, has established a…
Patients with systemic lupus erythematosus (SLE) report high levels of satisfaction when Benlysta (belimumab) therapy was self-administered using an autoinjector,…
Certain autoantibodies may help identify the small group of patients with systemic lupus erythematosus (SLE) at risk of developing pulmonary…